Fresenius Medical Care AG ADR FMS

Morningstar Rating
$22.17 +0.04 (0.18%)
View Full Chart

Company Report

Price vs Fair Value

FMS is trading at a LOCK|q>n>Xv! premium.
Price
$22.17
Fair Value
^vS
Uncertainty
LOCK|j?X
1-Star Price
LOCK|.H
5-Star Price
LOCK|.@
Economic Moat
LOCK|<pZ?
Capital Allocation
LOCK|@>%XRP

Bulls Say, Bears Say

Bulls

Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run.

Bears

With virtually all of its US service profits coming from commercial insurance, Fresenius' profits could contract in some negative policy scenarios.

News

Articles & Videos

Trading Information

Previous Close Price
$22.13
Day Range
$22.11–22.38
52-Week Range
$20.02–27.43
Bid/Ask
$21.45 / $23.83
Shares Outstanding
532.22M
Market Cap
$11.80B
Volume/Avg
620,938 / 797,971

Key Statistics

Price/Earnings (Normalized)
8.92
Price/Sales
0.55
Dividend Yield (Trailing)
3.93%
Dividend Yield (Forward)
3.93%
Dividend Payment Schedule
Jun
Total Yield
9.53%

Company Profile

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Mid Value
Total Number of Employees
108,165

Competitors

Valuation

Metric
FMS
DVA
THC
Price/Earnings (Normalized)
8.9214.6113.82
Price/Book Value
0.82—4.62
Price/Sales
0.550.941.03
Price/Cash Flow
4.025.765.43
Price/Earnings
FMS
DVA
THC

Financial Strength

Metric
FMS
DVA
THC
Quick Ratio
0.681.331.22
Current Ratio
1.071.471.41
Interest Coverage
4.763.475.71
Quick Ratio
FMS
DVA
THC

Profitability

Metric
FMS
DVA
THC
Return on Assets (Normalized)
4.50%7.71%5.60%
Return on Equity (Normalized)
10.75%—39.08%
Return on Invested Capital (Normalized)
6.66%12.79%10.73%
Return on Assets
FMS
DVA
THC

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Genesis Healthcare Inc Class A
GENNQ
LOCK|d^LOCK|^V—
HCA Healthcare Inc
HCA
LOCK|<f?>!jqLOCK|%jbW%$99B
Fresenius SE & Co KGaA ADR
FSNUY
—LOCK|%m<$$28B
Tenet Healthcare Corp
THC
LOCK|@?JgxkLOCK|KwlHt$22B
Encompass Health Corp
EHC
—LOCK|lV!&$13B
DaVita Inc
DVA
LOCK|?hH#r<LOCK|#q%r$12B
Fresenius Medical Care AG
FMCQF
—LOCK|%$Yq$12B
Universal Health Services Inc Class B
UHS
LOCK|M>Y%BgSLOCK|^V%B$11B
Ensign Group Inc
ENSG
—LOCK|%nF$N$10B

Sponsor Center